Treatment for tobacco smoking: A new alternative?

Medical Hypotheses

Volumn 79, Issue 6, 2012, Pages 867-868

  Zaparoli, Juçara Xavier ^a   Galduróz, José Carlos Fernandes ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; LINOLENIC ACID; NICOTINE; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TYRAMINE;

ARTICLE; DIET SUPPLEMENTATION; DOPAMINERGIC SYSTEM; DRUG EFFICACY; DRUG SAFETY; HUMAN; LIMBIC SYSTEM; MESOLIMBIC DOPAMINERGIC SYSTEM; NEGATIVE SYNDROME; NEUROTRANSMISSION; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE;

HUMANS; MODELS, THEORETICAL; SMOKING CESSATION; TOBACCO;

NICOTIANA TABACUM;

EID: 84869079255     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.09.009     Document Type: Article

References (26)

1. Balbani A.P., Montovani J.C. Methods for smoking cessation and treatment for nicotine dependence. Braz J Otorhinolaryngol 2005, 71(6):820-827.
2. Zaniewska M., Przegalinski E., Filip M. Nicotine dependence - human and animal studies current pharmacotherapies and future perspectives. Pharmacol Rep 2009, 61(6):957-965.
3. Jiloha R.C. Biological basis of tobacco addiction: implications for smoking-cessation treatment. Indian J Psychiatry 2010, 52(4):301-307.
4. Mansvelder H.D., McGehee D.S. Cellular and synaptic mechanisms of nicotine addiction. J Neurobiol 2002, 53(4):606-617.
5. Goodfellow L.T., Waugh J.B. Tobacco treatment and prevention: what works and why?. Respir Care 2009, 54(8):1082-1090.
6. D'Souza M.S., Markou A. Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments. Addict Sci Clin Pract 2011, 6(1):4-16.
7. Dyall S.C., Michael-Titus A.T. Neurological benefits of omega-3 fatty acids. Neuromolecular Med 2008, 10(4):219-235.
8. Spector A.A. Essentiality of fatty acids. Lipids 1999, 34:S1-S3.
9. Haag M. Essential fatty acids and the brain. Can J Psychiatry 2003, 48(3):195-203.
10. Fedacko J., Pella D., Mechírová V., et al. N-3 PUFAS-From dietary supplements to medicines. Pathophysiology 2007, 14(2):127-132.
11. Zimmer L., Delion-Vancassel S., Durant G., et al. Modification of dopamine neurotransmission in the nucleus accumbens of rats deficient in n-3 polyunsaturated fatty acids. J Lipid Res 2000, 41(1):32-40.
12. Chalon S., Vancassel S., Zimmer L., Guilloteau D., Durand G. Polyunsaturated fatty acids and cerebral function: focus on monoaminergic neurotransmission. Lipids 2001, 36(9):344-937.
13. Hallahan B., Hibbeln J.R., Davis J.M., Garland M.R. Omega-3 fatty acid supplementation in patients with recurrent self-harm. Br J Psychiatry 2007, 190:118-122.
14. Lakhan S.E., Vieira K.F. Nutritional therapies for mental disorders. Nutr J 2008, 21(7):2.
15. Ross B.M. Omega-3 polyunsaturated fatty acids and anxiety disorders. Prostaglandins Leukot Essent Fatty Acids 2009, 81(5-6):309-312.
16. Rusca A., Di Stefano A.F., Diog M.V., Scarsi C., Perucca E. Relative bioavailability and pharmacokinetics of two oral formulations of docosahexaenoic acid/eicosapentaenoic acid after multiple-dose administration in healthy volunteers. Eur J Clin Pharmacol 2009, 65(5):503-510.
17. Kapoor R., Patil U.K. Importance and production of omega-3 fatty acids from natural sources. Int Food Res J 2011, 18:493-499.
18. Zimmer L., Hembert S., Durand G., et al. Chronic n-3 polyunsaturated fatty acid diet-deficiency acts on dopamine metabolism in the rat frontal cortex: a microdialysis study. Neurosci Lett 1998, 240(3):177-181.
19. Chalon S. Omega-3 fatty acids and monoamine neurotransmission. Prostaglandins Leukot Essent Fatty Acids 2006, 75(4-5):259-269.
20. Zimmer L., Delpal S., Guilloteau D., Aïoun A., Durand G., Chalon S. Chronic n-3 polyunsaturated fatty acid deficiency alters dopamine vesicle density in the rat frontal cortex. Neurosci Lett 2000, 284(1-2):25-28.
21. Nitta H., Kinoyama M., Watanabe A., Shirao K., Kihara H., Arai M. Effects of nutritional supplementation with antioxidant vitamins and minerals and fish oil on antioxidant status and psychosocial stress in smokers: an open trial. Clin Exp Med 2007, 7(4):179-183.
22. Pawlosky R.J., Hibbeln J.R., Salem N. Compartmental analyses of plasma n-3 essential fatty acids among male and female smokers and nonsmokers. J Lipid Res 2007, 48(4):935-943.
23. Puri B.K., Treasaden I.H., Cocchi M., Tsaluchidu S., Tonello L., Ross B.M. A comparison of oxidative stress in smokers and non-smokers: an in vivo human quantitative study of n-3 lipid peroxidation. BMC Psychiatry 2008, 17(8):S1-S4.
24. Koob G.F., Sanna P.P., Bloom F.E. Neuroscience of addiction. Neuron 1998, 21(3):467-476.
25. Ventulani J. Drug addiction. Part II. Neurobiology of addiction. Pol J Pharmacol 2001, 53(4):303-317.
26. Dackis C.A., Gold M.S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Biobehav Rev 1985, 9(3):469-477.